DM
MXCT icon

Deerfield Management’s MaxCyte MXCT Stock Holding History

Deerfield Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,121
Closed -$52.2K – 150
2025
Q1 		$52.2K Buy
+19,121
New +$75.4K ﹤0.01% 114
2024
Q1 		– Sell
-50,031
Closed -$235K – 413
2023
Q4 		$235K Buy
+50,031
New +$195K ﹤0.01% 160

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management's MXCT Position: Q2 2025 in Review

Deerfield Management sold out of MaxCyte (MXCT) in Q2 2025, closing a stake of 19,121 shares — an estimated $52.2K sold.

Deerfield Management first reported a position in MXCT in Q4 2023 and held it in 2 quarters. The position peaked at $235K in Q4 2023. 120 funds tracked by Wall St. Rank hold MXCT as of Q2 2025.

  • Deerfield Management reported no remaining MaxCyte position as of Q2 2025 after selling out during the quarter.
  • Deerfield Management sold 19,121 MaxCyte shares in Q2 2025, an estimated $52.2K.
  • Deerfield Management first reported a position in MaxCyte in Q4 2023 and held it in 2 quarters.
  • Deerfield Management's MaxCyte position peaked at $235K in Q4 2023.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q2 2025.

Based on Deerfield Management's 13F filing for Q2 2025, filed 14 Aug 2025.